{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:06:46Z","timestamp":1789060006773,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["119445"],"award-info":[{"award-number":["119445"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001111","name":"Cancer Australia","doi-asserted-by":"publisher","award":["570996"],"award-info":[{"award-number":["570996"]}],"id":[{"id":"10.13039\/501100001111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["09\/624"],"award-info":[{"award-number":["09\/624"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1046425"],"award-info":[{"award-number":["1046425"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2000711"],"award-info":[{"award-number":["2000711"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004897","name":"European Organisation for Research and Treatment of Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000015","name":"Canadian Cancer Society Research Institute","doi-asserted-by":"publisher","award":["021039"],"award-info":[{"award-number":["021039"]}],"id":[{"id":"10.13039\/501100000015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejca.2026.117005","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T14:46:55Z","timestamp":1787410015000},"page":"117005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Older adults with resectable gastric cancer undergoing perioperative chemotherapy or preoperative chemoradiotherapy plus perioperative chemotherapy: A secondary analysis of the AGITG TOPGEAR phase III trial"],"prefix":"10.1016","volume":"246","author":[{"given":"Alexander","family":"R\u00fchle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L.","family":"O'Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Simes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard Mark","family":"Smithers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca K.S.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Haustermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils H.","family":"Nicolay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Lordick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2026.117005_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejca.2026.117005_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2026.117005_bib3","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"Al-Batran","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2026.117005_bib4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa2503701","article-title":"Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer","volume":"393","author":"Janjigian","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2026.117005_bib5","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJMoa2405195","article-title":"Preoperative Chemoradiotherapy for Resectable Gastric Cancer","volume":"391","author":"Leong","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2026.117005_bib6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4143\/crt.2016.054","article-title":"Adjuvant Chemotherapy for Advanced Gastric Cancer in Elderly and Non-elderly Patients: Meta-Analysis of Randomized Controlled Trials","volume":"49","author":"Chang","year":"2017","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.ejca.2026.117005_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.101980","article-title":"Challenges in the treatment of gastric cancer in the older patient","volume":"85","author":"Joharatnam-Hogan","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ejca.2026.117005_bib8","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1186\/s12889-024-19104-6","article-title":"Global incidence and mortality trends of gastric cancer and predicted mortality of gastric cancer by 2035","volume":"24","author":"Lin","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ejca.2026.117005_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ijc.31664","article-title":"Global cancer incidence in older adults, 2012 and 2035: A population-based study","volume":"144","author":"Pilleron","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2026.117005_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgo.2023.101657","article-title":"State of the scientific evidence and recommendations for the management of older patients with gastric cancer","volume":"15","author":"Paredero-P\u00e9rez","year":"2024","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.ejca.2026.117005_bib11","first-page":"115","article-title":"Prevalence and unfavorable outcome of frailty in older adults with gastric cancer: a systematic review and meta-analysis","volume":"32","author":"Tang","year":"2024","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ejca.2026.117005_bib12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejca.2020.02.008","article-title":"Older versus younger adults with gastric cancer receiving perioperative treatment: Results from the CRITICS trial","volume":"130","author":"Slagter","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.117005_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejca.2020.06.005","article-title":"Impact of sex and age on chemotherapy efficacy, toxicity and survival in localised oesophagogastric cancer: A pooled analysis of 3265 individual patient data from four large randomised trials (OE02, OE05, MAGIC and ST03)","volume":"137","author":"Athauda","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.117005_bib14","doi-asserted-by":"crossref","first-page":"6026","DOI":"10.21037\/tcr-20-2024","article-title":"Clinicopathological characteristics and survival outcomes of younger patients with gastric cancer: a systematic review and meta-analysis","volume":"9","author":"Niu","year":"2020","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.ejca.2026.117005_bib15","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10120-023-01404-2","article-title":"Neoadjuvant chemotherapy in older patients with gastric cancer undergoing surgery: a population-based cohort study","volume":"26","author":"Keywani","year":"2023","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ejca.2026.117005_bib16","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/bjc.2012.588","article-title":"Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer","volume":"108","author":"Lorenzen","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2026.117005_bib17","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.amjsurg.2020.03.006","article-title":"Gastric cancer management in elderly patients: a population-based study of treatment patterns and outcomes in gastric cancer patients \u2265 75 years from Alberta, Canada","volume":"221","author":"Schendel","year":"2021","journal-title":"Am J Surg"},{"key":"10.1016\/j.ejca.2026.117005_bib18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/XCS.0000000000001564","article-title":"Surgical Management of Gastric Cancer in Elderly Patients: Results of a Multicenter Cohort of the French Surgical Association","volume":"242","author":"Manceau","year":"2026","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ejca.2026.117005_bib19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12885-021-07919-0","article-title":"Survival analysis of elderly patients over 65 years old with stage II\/III gastric cancer treated with adjuvant chemotherapy after laparoscopic D2 gastrectomy: a retrospective cohort study","volume":"21","author":"Liang","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2026.117005_bib20","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1186\/s12885-023-11244-z","article-title":"The efficacy of adjuvant chemotherapy for older adults with stage II\/III gastric cancer: a retrospective cohort study","volume":"23","author":"Shih","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2026.117005_bib21","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s10120-015-0560-6","article-title":"Robotic gastrectomy for elderly gastric cancer patients: comparisons with robotic gastrectomy in younger patients and laparoscopic gastrectomy in the elderly","volume":"19","author":"Okumura","year":"2016","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ejca.2026.117005_bib22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10120-006-0409-0","article-title":"Impact of age on postoperative outcomes in 1118 gastric cancer patients undergoing surgical treatment","volume":"10","author":"Orsenigo","year":"2007","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ejca.2026.117005_bib23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4251\/wjgo.v9.i6.257","article-title":"Effects of age on survival and morbidity in gastric cancer patients undergoing gastrectomy","volume":"9","author":"Fujiwara","year":"2017","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.ejca.2026.117005_bib24","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1245\/s10434-016-5260-x","article-title":"Is Extended Lymphadenectomy Needed for Elderly Patients With Gastric Adenocarcinoma?","volume":"23","author":"Passot","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2026.117005_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14235927","article-title":"Specifics of Young Gastric Cancer Patients: A Population-Based Analysis of 46,110 Patients with Gastric Cancer from the German Clinical Cancer Registry Group","volume":"14","author":"Kist","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejca.2026.117005_bib26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.21873\/invivo.11463","article-title":"Comparison of Weight and Body Composition After Gastrectomy Between Elderly and Non-elderly Patients With Gastric Cancer","volume":"33","author":"Aoyama","year":"2019","journal-title":"In Vivo"},{"key":"10.1016\/j.ejca.2026.117005_bib27","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/jcsm.12477","article-title":"The Copenhagen Sarcopenia Study: lean mass, strength, power, and physical function in a Danish cohort aged 20-93 years","volume":"10","author":"Suetta","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ejca.2026.117005_bib28","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1245\/s10434-014-4296-z","article-title":"Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer","volume":"22","author":"Aoyama","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2026.117005_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16213697","article-title":"Real-World Outcomes for Localised Gastro-Oesophageal Adenocarcinoma Cancer Treated with Perioperative FLOT and Prophylactic GCSF Support in a Single Asian Centre","volume":"16","author":"Kee","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejca.2026.117005_bib30","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1007\/s10120-021-01228-y","article-title":"Clinical biomarkers in adjuvant chemotherapy for gastric cancer after D2 dissection by a pooled analysis of individual patient data from large randomized controlled trials","volume":"24","author":"Tsuburaya","year":"2021","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ejca.2026.117005_bib31","article-title":"Comparison of Treatment Efficacy and Survival Outcomes Between Asian and Western Patients With Unresectable Gastric or Gastro-Esophageal Adenocarcinoma: A Systematic Review and Meta-Analysis","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejca.2026.117005_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2026.117005_bib33","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S1470-2045(23)00515-6","article-title":"Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial","volume":"24","author":"Rha","year":"2023","journal-title":"Lancet Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926007860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926007860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:10:22Z","timestamp":1789056622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804926007860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":33,"alternative-id":["S0959804926007860"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.117005","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Older adults with resectable gastric cancer undergoing perioperative chemotherapy or preoperative chemoradiotherapy plus perioperative chemotherapy: A secondary analysis of the AGITG TOPGEAR phase III trial","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.117005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"117005"}}